89Zr-pembrolizumab-PET Imaging in Patients With Locally Advanced or Metastatic Melanoma or Non-small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Malignant melanoma
- Focus Diagnostic use
- 07 Jun 2017 Biomarkers information updated
- 12 Sep 2016 Status changed from not yet recruiting to recruiting.
- 07 Jun 2016 Planned number of patients changed from 20 to 21.